92 results
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
20 May 24
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
4:10pm
percutaneous procedure on a controlled and measured basis, statements concerning customer adoption and future use of the CellFX System to address a range
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
9 May 24
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
9:09am
on a controlled and measured basis, statements concerning customer adoption and future use of the CellFX System to address a range of conditions, such as benign
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
7 May 24
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
4:14pm
market opportunities, customer adoption and future use of the CellFX System to address a range of conditions such as atrial fibrillation, statements
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
2 May 24
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
9:09am
the Company to continue current operations as planned, statements concerning market opportunities, customer adoption and future use of the CellFX
8-K
EX-99.1
bb9 3o8zj
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
8-K
EX-99.2
jysjslq j305vabyu9ec
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
8-K
EX-99.1
8hh282syh6hc
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am
8-K
EX-99.1
kl04814tw7xrx4slush
14 Feb 24
Other Events
9:22am
8-K
EX-99.1
dykz iypw0y
2 Jan 24
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
9:20am
8-K
EX-99.1
5pg9wnkp8
20 Dec 23
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
9:06am
8-K
EX-99.1
y0s6g2euvva
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am